Summary & Overview
CPT 54535: Radical Orchiectomy With Abdominal Exploration
CPT code 54535 denotes a radical orchiectomy with abdominal exploration performed to remove one or both testes for tumor treatment and to evaluate for intra‑abdominal disease spread. The code captures a definitive diagnostic and therapeutic surgical intervention for testicular neoplasms and is used in hospital and ambulatory surgical settings where general anesthesia and abdominal assessment are required. Nationally, this code is significant because it represents a key surgical approach in testicular cancer management and often triggers perioperative, inpatient, and oncologic care pathways.
Key payers covered in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise clinical context for the procedure, common billing and coding considerations, and what to expect in terms of site of service and service type. The publication outlines benchmark and policy-relevant issues affecting coverage and billing for surgical oncology procedures, and it summarizes operational implications for facilities and surgical teams. The summary provides guidance on where to find additional coding detail and highlights areas where supplemental documentation may be required. Data not available in the input for specific payer policy differences, associated taxonomies, ICD-10 diagnoses, and related codes.
Billing Code Overview
CPT code 54535 describes a surgical procedure in which the provider excises one or both testes to treat a tumor and performs an abdominal exploration to assess for intra‑abdominal spread of disease. This procedure is a radical orchiectomy with abdominal exploration performed for suspected or confirmed testicular neoplasm.
Service type: Surgical — oncologic testicular surgery with abdominal exploration
Typical site of service: Hospital operating room or ambulatory surgical center with intra‑abdominal access, often requiring general anesthesia and perioperative surgical support.
Clinical & Coding Specifications
Clinical Context
A 32-year-old male presents with a palpable, firm testicular mass and rising serum alpha-fetoprotein and beta-hCG levels. Scrotal ultrasound confirms a solid intratesticular lesion suspicious for malignancy. The urologic oncology team recommends a radical inguinal orchiectomy with abdominal exploration to evaluate for retroperitoneal or peritoneal spread.
Preoperative workflow includes history and physical, tumor markers (AFP, beta-hCG, LDH), scrotal ultrasound, cross-sectional imaging of the abdomen/pelvis (CT or MRI) as indicated, and anesthesia evaluation. The procedure is performed via an inguinal approach: the spermatic cord is ligated high at the internal inguinal ring, and one or both testes are excised. The surgeon then performs abdominal exploration (palpation, inspection, and selective biopsies or lymph node assessment) to assess for metastatic disease. Specimens are sent to pathology and tumor markers are trended postoperatively. Typical postoperative care includes pain control, wound care, activity restrictions, and oncologic staging discussions with medical oncology for adjuvant therapy if indicated.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
50 | Bilateral Procedure | Use when both testes are excised during the same operative session. |